CHICAGO Data presented from Edwards Lifescience's (Irvine, California) PARTNER trial at the American College of Cardiology's (ACC; Washington) 61st Annual Scientific Session and Expo on Monday, bolsters a less-invasive procedure using the firm's Sapien transcatheter heart valve and shows that the device has strong performance at two years. Read More
